Scarica l'app Stockscreener
12.18
1.46%
-0.18
Dopo l'orario di chiusura:
12.16
-0.02
-0.16%
Precedente Chiudi:
$12.36
Aprire:
$12.46
Volume 24 ore:
600.36K
Relative Volume:
0.27
Capitalizzazione di mercato:
$864.09M
Reddito:
-
Utile/perdita netta:
$-297.11M
Rapporto P/E:
-2.3468
EPS:
-5.19
Flusso di cassa netto:
$-216.95M
1 W Prestazione:
+2.27%
1M Prestazione:
+41.30%
6M Prestazione:
+111.46%
1 anno Prestazione:
-25.28%
Intervallo 1D:
$11.78
$12.46
Intervallo di 1 settimana:
$11.42
$12.96
Portata 52W:
$2.21
$19.71
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
Nome
Phathom Pharmaceuticals Inc
Settore
Industria
Telefono
(877) 742-8466
Indirizzo
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Confronta PHAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHAT
Phathom Pharmaceuticals Inc
|
12.18 | 876.86M | 0 | -297.11M | -216.95M | -5.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-03 | Iniziato | Stifel | Buy |
| 2024-01-05 | Reiterato | Needham | Buy |
| 2023-08-09 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-13 | Iniziato | Craig Hallum | Buy |
| 2022-10-21 | Iniziato | Jefferies | Buy |
| 2022-05-06 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-05-12 | Aggiornamento | Goldman | Sell → Neutral |
| 2021-02-17 | Iniziato | BMO Capital Markets | Outperform |
| 2021-02-02 | Iniziato | Guggenheim | Buy |
| 2020-06-26 | Downgrade | Goldman | Neutral → Sell |
| 2019-11-20 | Iniziato | Evercore ISI | Outperform |
| 2019-11-19 | Iniziato | Goldman | Neutral |
| 2019-11-19 | Iniziato | Jefferies | Buy |
| 2019-11-19 | Iniziato | Needham | Buy |
Mostra tutto
Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie
Momentum divergence signals in Phathom Pharmaceuticals Inc. chartTrade Exit Summary & Stepwise Trade Signal Implementation - Newser
Is Phathom Pharmaceuticals Inc. a top pick in the sectorWeekly Earnings Recap & Growth Oriented Trading Recommendations - خودرو بانک
Why Phathom Pharmaceuticals Inc. is moving todayJuly 2025 Trade Ideas & Fast Gaining Stock Reports - Newser
Combining machine learning predictions for Phathom Pharmaceuticals Inc.July 2025 Selloffs & Risk Managed Investment Strategies - Newser
Signal strength of Phathom Pharmaceuticals Inc. stock in tech scannersPortfolio Risk Report & Comprehensive Market Scan Insights - Newser
How to read the order book for Phathom Pharmaceuticals Inc.Market Volume Summary & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-08-31 22:05:23 - Newser
Backtesting results for Phathom Pharmaceuticals Inc. trading strategiesPortfolio Value Report & Accurate Trade Setup Notifications - Newser
Will a bounce in Phathom Pharmaceuticals Inc. offer an exitJuly 2025 Technicals & Entry Point Strategy Guides - Newser
Can a trend reversal in Phathom Pharmaceuticals Inc. lead to recoveryEarnings Growth Summary & Stepwise Swing Trade Plans - Newser
Phathom Pharmaceuticals Inc. stock retracement – recovery analysis2025 Retail Activity & Real-Time Price Movement Reports - Newser
Detecting support and resistance levels for Phathom Pharmaceuticals Inc.July 2025 Sentiment & AI Based Buy/Sell Signal Reports - Newser
Advanced analytics toolkit walkthrough for Phathom Pharmaceuticals Inc.Quarterly Profit Report & Long-Term Investment Growth Plans - Newser
Is Phathom Pharmaceuticals Inc. the Top Chart Pick This Week getLinesFromResByArray error: size == 0 - thegnnews.com
What’s next for Phathom Pharmaceuticals Inc. stock priceTrade Analysis Summary & Weekly High Return Stock Opportunities - Newser
What the charts say about Phathom Pharmaceuticals Inc. today2025 Sector Review & Daily Chart Pattern Signal Reports - Newser
Published on: 2025-08-31 04:29:11 - Newser
What makes Phathom Pharmaceuticals Inc. stock price move sharplyWeekly Trend Summary & Risk Managed Investment Strategies - Newser
Published on: 2025-08-31 02:28:01 - Newser
How hedge fund analytics apply to Phathom Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
Can you recover from losses in Phathom Pharmaceuticals Inc.Trade Risk Summary & Technical Pattern Based Signals - Newser
Historical volatility pattern of Phathom Pharmaceuticals Inc. visualizedPortfolio Return Summary & Precise Entry and Exit Recommendations - Newser
Analysts Apply Wyckoff Model to Phathom Pharmaceuticals Inc. Stock getLinesFromResByArray error: size == 0 - thegnnews.com
Is Phathom Pharmaceuticals Inc. building a consolidation baseCPI Data & Daily Profit Maximizing Tips - Newser
Intraday Charts Show Spike in Phathom Pharmaceuticals Inc. Activity getLinesFromResByArray error: size == 0 - kangso.co.kr
How moving averages guide Phathom Pharmaceuticals Inc. tradingMarket Volume Report & Fast Exit/Entry Strategy Plans - Newser
Using data filters to optimize entry into Phathom Pharmaceuticals Inc.Quarterly Earnings Summary & AI Powered Buy and Sell Recommendations - Newser
Visual trend scoring systems applied to Phathom Pharmaceuticals Inc.Market Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Multi asset correlation models including Phathom Pharmaceuticals Inc.Market Volume Report & High Win Rate Trade Alerts - Newser
Phathom Pharmaceuticals Inc Azioni (PHAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Phathom Pharmaceuticals Inc Azioni (PHAT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Topper James N | Director |
May 21 '25 |
Buy |
3.86 |
3,780 |
14,609 |
59,403 |
| Topper James N | Director |
May 14 '25 |
Buy |
3.32 |
6,300 |
20,919 |
55,623 |
| Topper James N | Director |
May 13 '25 |
Buy |
3.16 |
1,120 |
3,543 |
49,323 |
| Topper James N | Director |
May 09 '25 |
Buy |
3.22 |
35,602 |
114,616 |
35,602 |
| Topper James N | Director |
May 12 '25 |
Buy |
3.04 |
12,601 |
38,301 |
48,203 |
| Parikh Asit | Director |
May 06 '25 |
Buy |
2.60 |
5,000 |
13,000 |
90,500 |
| Parikh Asit | Director |
May 07 '25 |
Buy |
2.40 |
5,000 |
11,984 |
95,500 |
| Henderson Molly | CFO and CBO |
Apr 07 '25 |
Sale |
4.55 |
3,678 |
16,740 |
89,868 |
| Parikh Asit | Director |
Sep 10 '24 |
Option Exercise |
11.72 |
7,500 |
87,900 |
93,000 |
| Parikh Asit | Director |
Mar 13 '25 |
Buy |
4.42 |
10,000 |
44,200 |
85,500 |
0.96%
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):